| RS190593027 |
HTT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS190598500 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS1905998196 |
SUZ12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Imagawa-Matsumoto syndrome |
| RS190600127 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1906033837 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS190604150 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1906051274 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS1906054627 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS190605644 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1906069048 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS1906110243 |
ZNF469
|
Health Risk |
Pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS190612616 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, SKIN/HAIR/EYE PIGMENTATION 1 |
| RS1906134276 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1906146144 |
COX4I1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS1906174955 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS190617851 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS190619495 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, DTNA-related disorder |
| RS190620963 |
ADAM9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 9, Cone-rod dystrophy 9 |
| RS190623423 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS190624357 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1906247824 |
COX4I1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 16 |
| RS190626072 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1906263385 |
PMP22
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS190628299 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1906290133 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1906294453 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS190631679 |
ALDOB
|
Health Risk |
Pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS190636272 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS190640695 |
PIK3C2A
|
Health Risk |
Conflicting classifications of pathogenicity |
PIK3C2A-related disorder, PIK3C2A-related disorder |
| RS190642059 |
ROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1906421838 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906423537 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906450508 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1906465563 |
DGKE
|
Health Risk |
Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1906488067 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906529223 |
DGKE
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS190652985 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1906536457 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, COL1A1-related disorder |
| RS1906537608 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type III |
| RS190654033 |
ERBB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 19, Amyotrophic lateral sclerosis type 19 |
| RS190655078 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase complex deficiency |
| RS1906559620 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Infantile cortical hyperostosis |
| RS1906565901 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS190657753 |
SPINK5
|
Health Risk |
Conflicting classifications of pathogenicity |
Netherton syndrome, Ichthyosis linearis circumflexa |
| RS1906581372 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1906585690 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906591346 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1906604347 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1906658881 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906659084 |
COL1A1
|
Health Risk |
Likely pathogenic |
Infantile cortical hyperostosis, Infantile cortical hyperostosis |
| RS1906662179 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS190666668 |
COL6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
COL6A5-related disorder, COL6A5-related disorder |
| RS1906687546 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1906688548 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1906689587 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1906695650 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906697955 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1906699127 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS190673127 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS190673256 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS190674457 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS1906756953 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1906761196 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1906767501 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906773628 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS190680402 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 |
| RS190680511 |
CEP41
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 15, CEP41-related disorder |
| RS190680846 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS190681011 |
PAX8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism, congenital |
| RS1906818829 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906821006 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906821341 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1906842230 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906843530 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906846472 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906847588 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS190685228 |
CTAGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1906853874 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906866028 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906868595 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906874191 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906875264 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS1906878217 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS190688700 |
OFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome I, Joubert syndrome |
| RS1906910979 |
KRT9
|
Health Risk |
Pathogenic |
— |
| RS190692217 |
MAN2C1
|
Health Risk |
Likely pathogenic |
Congenital disorder of deglycosylation 2, Congenital disorder of deglycosylation 2 |
| RS190692435 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis, Inborn genetic diseases |
| RS190693455 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS1906936483 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1906940130 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS1906940342 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS190695126 |
COQ8B
|
Health Risk |
Pathogenic |
— |
| RS190695638 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1906960583 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS190698163 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1906989648 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta |
| RS1907006084 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1907006410 |
MLYCD
|
Health Risk |
Likely pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS190701197 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS1907020116 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |